Novel drugs that target the metabolic reprogramming in renal cell cancer

Molecular profiling studies of tumor tissue from patients with clear cell renal cell cancer (ccRCC) have revealed extensive metabolic reprogramming in this disease. Associations were found between metabolic reprogramming, histopathologic Fuhrman grade, and overall survival of patients. Large-scale g...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Mijn, Johannes C., Panka, David J., Geissler, Andrew K., Verheul, Henk. M., Mier, James W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944519/
https://www.ncbi.nlm.nih.gov/pubmed/27418963
http://dx.doi.org/10.1186/s40170-016-0154-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944519/
https://www.ncbi.nlm.nih.gov/pubmed/27418963
http://dx.doi.org/10.1186/s40170-016-0154-8

Ejemplares similares